Gemcitabine and mitoxantrone in metastatic breast cancer: A phase-I-study

Author： Schmid Peter Flath Bernd Akrivakis Konstantin Heilmann Volker Mergenthaler Hans-Günther Sezer Orhan Kreienberg Rolf Possinger Kurt

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.23, Iss.4, 2005-08, pp. : 349-356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prolonged infusion of gemcitabine in advanced solid tumors: A phase-I-study

By Schmid Peter Schweigert Marcus Beinert Thomas Flath Bernd Sezer Orhan Possinger Kurt

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 139-146

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer

By Park In Ro Jungsil Lee Keun Kim Shi Yun Young Nam Byung

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 659-669

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine boosts paclitaxel efficacy in metastatic breast cancer

Inpharma, Vol. 1, Iss. 1453, 2004-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes

By Chan Daniel Yeo Wee-Lee Tiemsim Cordero Maricel Wong Chiung-Ing Chuah Benjamin Soo Ross Tan Sing-Huang Lim Siew-Eng Goh Boon-Cher Lee Soo-Chin

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 859-865

Springer Publishing Company

Access to resources Recommend Favorite

Phase III study of IMC 1121B for metastatic breast cancer begins.

Inpharma, Vol. 1, Iss. 1652, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite